LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 1 | H24 | 72 | hr | 1694 | 7617 | 11220 | 0.6788 | 0.7352 |
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 2 | H24 | 72 | hr | 1694 | 7730 | 11309 | 0.6835 | 0.7406 |
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 3 | H24 | 72 | hr | 1694 | 7775 | 11121 | 0.6991 | 0.7529 |
MCF 10A | GSK1904529A | 0.12 | uM | LJP6 | 1 | H23 | 72 | hr | 1694 | 6909 | 11220 | 0.6157 | 0.6742 |
MCF 10A | GSK1904529A | 0.12 | uM | LJP6 | 2 | H23 | 72 | hr | 1694 | 7385 | 11309 | 0.6530 | 0.7118 |
MCF 10A | GSK1904529A | 0.12 | uM | LJP6 | 3 | H23 | 72 | hr | 1694 | 7450 | 11121 | 0.6699 | 0.7256 |
MCF 10A | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 1694 | 6337 | 11220 | 0.5648 | 0.6220 |
MCF 10A | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 1694 | 6641 | 11309 | 0.5872 | 0.6467 |
MCF 10A | GSK1904529A | 0.37 | uM | LJP6 | 3 | H22 | 72 | hr | 1694 | 6971 | 11121 | 0.6268 | 0.6839 |
MCF 10A | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 1694 | 6364 | 11220 | 0.5672 | 0.6245 |
MCF 10A | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 1694 | 6110 | 11309 | 0.5403 | 0.5973 |
MCF 10A | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 1694 | 6316 | 11121 | 0.5679 | 0.6237 |
MCF 10A | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1694 | 6021 | 11220 | 0.5366 | 0.5919 |
MCF 10A | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1694 | 6732 | 11309 | 0.5953 | 0.6549 |
MCF 10A | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1694 | 6126 | 11121 | 0.5508 | 0.6056 |
MCF 10A | GSK1904529A | 10 | uM | LJP6 | 1 | H19 | 72 | hr | 1694 | 6267 | 11220 | 0.5585 | 0.6154 |
MCF 10A | GSK1904529A | 10 | uM | LJP6 | 2 | H19 | 72 | hr | 1694 | 6321 | 11309 | 0.5589 | 0.6173 |
MCF 10A | GSK1904529A | 10 | uM | LJP6 | 3 | H19 | 72 | hr | 1694 | 6400 | 11121 | 0.5755 | 0.6317 |
MCF 10A | Linsitinib | 0.04 | uM | LJP5 | 1 | O24 | 72 | hr | 1694 | 10322 | 11042 | 0.9348 | 0.9507 |
MCF 10A | Linsitinib | 0.04 | uM | LJP5 | 2 | O24 | 72 | hr | 1694 | 10382 | 11099 | 0.9354 | 0.9513 |
MCF 10A | Linsitinib | 0.04 | uM | LJP5 | 3 | O24 | 72 | hr | 1694 | 10491 | 11168 | 0.9394 | 0.9545 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 1694 | 9754 | 11042 | 0.8833 | 0.9103 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 1694 | 9738 | 11099 | 0.8773 | 0.9058 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 1694 | 9765 | 11168 | 0.8744 | 0.9037 |
MCF 10A | Linsitinib | 0.37 | uM | LJP5 | 1 | O22 | 72 | hr | 1694 | 9231 | 11042 | 0.8360 | 0.8718 |